ZafGen (Cambridge, MA) a clinical-stage company focused on small molecule therapeutics for the treatment of obesity, closed a $8.1M Series B financing, bringing the total round to $28M. Participants include Atlas Venture, Third Rock Ventures and GreatPoint Ventures.